Target Xtra Detachable Coil
Device, Neurovascular Embolization. 510(k) K261772, from Stryker Neurovscular (Fremont, CA). Product code HCG, class 2.
As of Nov 20, 2026, K261772 is an FDA 510(k) held by Stryker Neurovscular, substantially equivalent on Jun 24, 2026 after 26 days, with no recalls tied to it in FDA's recall database.
- Review time: 26 days
- Recalls: 0
Please type in the marketing application/submission number, if it is known. This textbox will be left blank for original applications/submissions. K261772 ? Please provide the device trade name(s). ? Target Xtra Detachable Coil Please provide your Indications for Use below.
- Target Detachable CoilK252694 · Stryker Neurovascular · Dec 11, 2025
- Micrusframe (MFR100202); Micrusframe (MFR100253); Micrusframe (MFR100305); Micrusframe (MFR100356); Micrusframe…K262419 · Cerenovus, Inc. · Aug 14, 2026
- Numen™ Helia Coil Embolization System; NumenFR™ Detachment SystemK260351 · MicroPort NeuroTech (Shanghai) Co., Ltd. · May 20, 2026
- Optima Coil System (OptiOne Coil System)K254221 · Balt USA, LLC · Jan 27, 2026
- Target Detachable CoilK252694 · Stryker Neurovascular · Dec 11, 2025
- InZone IST Detachment System; IZDS Connecting CableK251832 · Stryker Neurovascular · Oct 17, 2025
- Optima Coil System (Optima Packing Coil System)K252700 · Balt USA, LLC · Sep 26, 2025
- Numen™ Coil Embolization System; NumenFR™ Detachment SystemK242154 · MicroPort NeuroTech (Shanghai) Co., Ltd. · Sep 30, 2024
- Optima Coil System (OptiBlock Line Extension)K242582 · Balt USA, LLC · Sep 27, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- May 29, 2026
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5950
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files